Sinofn Health
In the rapidly evolving landscape of nutraceuticals, SINOFN Health Co., Ltd. stands as a cornerstone of industrial excellence. Founded in 2012 with deep roots in the Chinese Academy of Sciences (CAS), we have transitioned from clinical research in rare metabolic disorders to becoming a global leader in OEM/ODM bulk supplement manufacturing. Our commitment is defined by Information Gain—we don't just manufacture; we provide the intellectual property, regulatory navigation, and supply chain transparency that global brands require to scale.
Our focus on NMN (Nicotinamide Mononucleotide) and metabolic health supplements is built on rigorous bio-availability validation. Unlike standard manufacturers, SINOFN leverages a cross-disciplinary R&D approach led by PhD-level experts. Our technical roadmap integrates:
Navigating the "Regulatory Maze" of international health supplements is a SINOFN core competency. We provide:
Dr. Tan Shengjie, with 15+ years of metabolic formulation experience, leads our efforts in translating clinical data into commercial wellness solutions.
Dr. Zhang Ying, Postdoc from CAS, specializes in advanced molecular delivery, ensuring your supplements reach the cellular targets effectively.
Hans van Dijk, our EU-based chief engineer, bridges the gap between Asian manufacturing precision and European quality standards.
Q: How does SINOFN ensure the purity of NMN bulk supplements?
A: We employ HPLC and GC-MS testing across multiple stages. Our CAS-affiliated lab validates every batch for heavy metals, purity, and residual solvents, exceeding standard GMP requirements.
Q: Do you offer rapid prototyping for new supplement brands?
A: Yes. We maintain pilot-scale production lines specifically designed to iterate formulations quickly, allowing clients to test market viability before full-scale commercialization.
Q: How do you support the compliance requirements for international markets?
A: Our regulatory affairs team provides comprehensive documentation packets, including COAs, allergen reports, and stability data required for FDA, Health Canada, and European market entry.